Re-induction for loss of response or non-response with adalimumab every other week-Ruby study

Not Applicable

• Conditions: Crohn' s disease

• Registration Number: JPRN-UMIN000011175
• Lead Sponsor: Department of Gastroenterology and Hepatology, Kyoto University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-11
• Study Completion: 2016-05-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients < 15 years of age (2) Patients who are pregnant or likely to be pregnant women (3) Patients with severe infection (4) Patients who underwent surgery within 3 months (5) Patients with severe intestinal structures (6) Patients with malignancy (7) Patients not approving the study consent (8) Patients judged as inappropriate for enrollment by physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified